<SEC-DOCUMENT>0001257809-25-000003-index.html : 20250908 <SEC-HEADER>0001257809-25-000003.hdr.sgml : 20250908 <ACCEPTANCE-DATETIME>20250908180631 ACCESSION NUMBER: 0001257809-25-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20250905 FILED AS OF DATE: 20250908 DATE AS OF CHANGE: 20250908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCORMICK FRANK CENTRAL INDEX KEY: 0001257809 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 251301146 MAIL ADDRESS: STREET 1: C/O UCSF, 1450 3RD STREET STREET 2: RM HD-371 CITY: SAN FRANCISCO STATE: CA ZIP: 941439001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>wk-form4_1757369187.xml <DESCRIPTION>FORM 4 <TEXT> Document 1 - file: wk-form4_1757369187.html
Document 1 - RAW XML: wk-form4_1757369187.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24.HTM <SEQUENCE>2 <FILENAME>bbio-poaforsection16repo.htm <DESCRIPTION>EX-24.HTM <TEXT> Document 2 - file: bbio-poaforsection16repo.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>bbio-poaforsection16repo001.jpg <TEXT> Document 3 - file: bbio-poaforsection16repo001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>bbio-poaforsection16repo002.jpg <TEXT> Document 4 - file: bbio-poaforsection16repo002.jpg
</DOCUMENT> </SEC-DOCUMENT>